Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries

Hypertension

Volumn 36, Issue 4, 2000, Pages 617-621

  Matrougui, K ^a   Eskildsen Helmond, Y E G ^a   Fiebeler, A ^c   Henrion, D ^b   Levy, B I ^b   Tedgui, A ^b   Mulvany, M J ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b HÔPITAL LARIBOISIÈRE   (France)

^c FRANZ VOLHARD CLINIC   (Germany)

Author keywords

Angiotensin II; Mesenteric arteries; Protein kinases; Rats; Receptors, angiotensin II

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; GENISTEIN; HERBIMYCIN A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHENYLEPHRINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESISTANCE BLOOD VESSEL; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 0033778403     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.4.617     Document Type: Article

References (34)

1. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells
2. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries
3. Signal transduction of mechanical stresses in the vascular wall
4. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells
5. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism
6. Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure
7. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
8. MAP kinases and vascular smooth muscle function
9. Angiotensin II signal transduction in vascular smooth muscle: Pathways activated by specific tyrosine kinases
10. Ca(2+)-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype
11. High sodium intake decreases pressure-induced (myogenic) tone and flow-induced dilation in resistance arteries from hypertensive rats
12. Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin
13. 2+-sensitization of force production by noradrenaline in rat mesenteric small arteries
14. Increased pressure induces sustained protein kinase C-independent herbimycin A-sensitive activation of extracellular signal-related kinase 1/2 in the rabbit aorta in organ culture
15. The pathophysiology of hypertension: The importance of angiotensin II in cardiovascular remodeling
16. Vascular hypertrophy in hypertension: Role of the reninangiotensin system
17. Acute hypertension activates mitogen-activated protein kinases in arterial wall
18. Activation of mitogen-activated protein kinae in porcine carotid arteries
19. Stretch induces mitogen-activated protein kinase activation and myogenic tone through 2 distinct pathways
20. Integrin-mediated cell adhesion activates mitogen-activated protein kinases
21. Integrin-dependent activation of MAP kinase: A link to shape-dependent cell proliferation
22. A role for MAP kinase in differentiated smooth muscle contraction evoked by alpha-adrenoceptor stimulation
23. 5-Hydroxytryptamine-induced potentiation of endothelin-1- and norepinephrine-induced contraction is mitogen-activated protein kinase pathway dependent
24. Nonspecific inhibition of myogenic tone by PD98059, a MEK1 inhibitor, in rat middle cerebral arteries
25. Angiotensin II regulates vascular smooth muscle pH, contraction, and growth via tyrosine kinase-dependent signaling pathways
26. Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
27. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
28. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells
29. Pulsatile stretch activates mitogen-activated protein kinase (MAPK) family members and focal adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes
30. Role of calcium-sensitive tyrosine kinase Pyk2/CAKbeta/RAFTK in angiotensin II-induced Ras/ERK signaling
31. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells
32. Angiotonsin II signal transduction in vascular smooth muscle: Role of tyrosine kinases
33. cSrc is a major cytosolic tyrosine kinase in vascular tissue
34. Cell type-specific angiotensin II-evoked signal transduction pathways: Critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts